This educational activity is directed toward hematologists. Pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with iron overload are also invited to attend.
Patients who require ongoing red blood cell transfusions, such as individuals with transfusion-dependent thalassemia or sickle cell disease, may develop iron overload. Severe or long-term iron overload can result in a higher risk of a variety of complications, including hepatic dysfunction, heart failure and arrhythmias, and endocrine complications.
In this program, experts take learners through a comprehensive review of transfusion-related iron overload, taking a deep dive into the optimal use of chelation therapy, with specific approaches to patients with sickle cell disease and thalassemia major.
This educational activity is an archive of the live virtual presentation held on December 9, 2022.